Home
C4 Therapeutics

C4 Therapeutics Market Share Analysis for August 2026

European Union (“EU”) Regulation EU 2016/679 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (the “General Data Protection Regulation” or “EU GDPR”) and the Retained Regulation (EU) 2016/679 (“UK GDPR”) (collectively the “GDPRs”), require C4 Therapeutics, Inc. (“C4T”, “We”, “Our”, or […]

Science and Education > Biology

Domainc4therapeutics.com

Year Founded2010

Employees51 - 200

Annual Revenue$25M - $50M

C4 Therapeutics

C4 Therapeutics (including company regionals)

c4therapeutics.com

See more website traffic and engagement information

C4 Therapeutics Revenue up to August 2026 is 25M - 50M

revenue generated by C4 Therapeutics top domains

C4 Therapeutics top domains revenue over 3 years

Revenue for C4 Therapeutics top domains

c4therapeutics.com25M - 50M

See more with Sales Intelligence

Total visits to C4 Therapeutics's top domains

Understand C4 Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

c4therapeutics.com5.8K

See more with Sales Intelligence

Avg. visit duration in C4 Therapeutics's top domains

Analyze C4 Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

c4therapeutics.com00:00:38

See more with Sales Intelligence

Avg. pageviews on C4 Therapeutics's top domains

See how C4 Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

c4therapeutics.com2.15

See more with Sales Intelligence

C4 Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

rigel.comCompany NameRigel PharmaceuticalsEmployees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$200M - $500MTotal visits10.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by C4 Therapeutics

These are the website technologies, by industry, used by C4 Therapeutics top domains

Payment & Currencies (10)

Cart Functionality

Social (9)

Google+ Platform

Widget (8)

Twemoji

Advertising (7)

DoubleClick

More Technologies

11

See all

News & Signals from C4 Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsC4 Therapeutics, Inc. will attend event 23rd IMS Annual Meeting on Sep 25th '26.WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) - C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that new biomarker data on the immunomodulatory effects of cemsidomide in combination with dexamethasone from its Phase 1 trial for relapsed/refractory multiple myeloma (RRMM) will be presented in a poster at the 23rd IMS Annual Meeting.

NewsC4 Therapeutics, Inc. had revenue of $6.64M on Jul 1st '26.* C4 Therapeutics reported a quarterly loss of $0.18 per share, beating the consensus loss estimate of $0.23, while revenue of $6.64 million exceeded expectations of $4.00 million.

NewsC4 Therapeutics, Inc. identified as competitor of Bristol-Myers Squibb Co on May 1st '26.C4 Therapeutics' stock price appreciated ahead of competitor Bristol Myers Squibb's data presentation at the American Society of Clinical Oncology (ASCO) conference for its drug mezigdomide, a drug with a comparable mechanism of action to C4's cemsidomide for the treatment of multiple myeloma.